These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17077558)

  • 1. Quantitative structure-activity relationships of selective antagonists of glucagon receptor using QuaSAR descriptors.
    Manoj Kumar P; Karthikeyan C; Hari Narayana Moorthy NS; Trivedi P
    Chem Pharm Bull (Tokyo); 2006 Nov; 54(11):1586-91. PubMed ID: 17077558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substituted imidazoles as glucagon receptor antagonists.
    Chang LL; Sidler KL; Cascieri MA; de Laszlo S; Koch G; Li B; MacCoss M; Mantlo N; O'Keefe S; Pang M; Rolando A; Hagmann WK
    Bioorg Med Chem Lett; 2001 Sep; 11(18):2549-53. PubMed ID: 11549467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free-energy force-field three-dimensional quantitative structure-activity relationship analysis of a set of p38-mitogen activated protein kinase inhibitors.
    Romeiro NC; Albuquerque MG; de Alencastro RB; Ravi M; Hopfinger AJ
    J Mol Model; 2006 Sep; 12(6):855-68. PubMed ID: 16541250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR study on hetaryl imidazoles: a novel dual inhibitor of VEGF receptors I and II.
    Patel A; Karthikeyan C; Moorthy NS; Trivedi P
    Med Chem; 2010 Jan; 6(1):24-9. PubMed ID: 20402657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel 3D-QSAR comparative molecular field analysis (CoMFA) model of imidazole and quinazolinone functionalized p38 MAP kinase inhibitors.
    Sperandio da Silva GM; Sant'Anna CM; Barreiro EJ
    Bioorg Med Chem; 2004 Jun; 12(12):3159-66. PubMed ID: 15158784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking.
    Ravindra GK; Achaiah G; Sastry GN
    Eur J Med Chem; 2008 Apr; 43(4):830-8. PubMed ID: 17706839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Structure-Activity Relationship Study of Imidazole-5-Carboxylic Acid Derivatives as Angiotensin II Receptor Antagonists Combining 2D and 3D QSAR Methods.
    Sharma MC
    Interdiscip Sci; 2016 Mar; 8(1):1-10. PubMed ID: 26202941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.
    Istyastono EP; Nijmeijer S; Lim HD; van de Stolpe A; Roumen L; Kooistra AJ; Vischer HF; de Esch IJ; Leurs R; de Graaf C
    J Med Chem; 2011 Dec; 54(23):8136-47. PubMed ID: 22003888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition activity prediction for a dataset of candidates' drug by combining fuzzy logic with MLR/ANN QSAR models.
    Abdolmaleki A; Ghasemi JB
    Chem Biol Drug Des; 2019 Jun; 93(6):1139-1157. PubMed ID: 31343121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR study of substituted 2-pyridinyl guanidines as selective urokinase-type plasminogen activator (uPA) inhibitors.
    Karthikeyan C; Moorthy NS; Trivedi P
    J Enzyme Inhib Med Chem; 2009 Feb; 24(1):6-13. PubMed ID: 19012070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative structure-activity relationship studies of TIBO derivatives using support vector machines.
    Darnag R; Schmitzer A; Belmiloud Y; Villemin D; Jarid A; Chait A; Mazouz E; Cherqaoui D
    SAR QSAR Environ Res; 2010 Apr; 21(3-4):231-46. PubMed ID: 20544549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
    Wang XS; Tang H; Golbraikh A; Tropsha A
    J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and three-dimensional quantitative structure-activity relationship analysis of H3 receptor antagonists containing a neutral heterocyclic polar group.
    Rivara S; Mor M; Bordi F; Silva C; Zuliani V; Vacondio F; Morini G; Plazzi PV; Carrupt PA; Testa B
    Drug Des Discov; 2003; 18(2-3):65-79. PubMed ID: 14675944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular docking, 3D-QSAR and structural optimization on imidazo-pyridine derivatives dually targeting AT1 and PPARg.
    Zhang J; Hao QQ; Liu X; Jing Z; Jia WQ; Wang SQ; Xu WR; Cheng XC; Wang RL
    Oncotarget; 2017 Apr; 8(15):25612-25627. PubMed ID: 28445965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer.
    Nagar S; Saha A
    J Comput Chem; 2010 Sep; 31(12):2342-53. PubMed ID: 20340106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies.
    Salum Lde B; Polikarpov I; Andricopulo AD
    J Mol Graph Model; 2007 Sep; 26(2):434-42. PubMed ID: 17349808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A QSAR study using MTD method and Dragon descriptors for a series of selective ligands of α2C adrenoceptor.
    Borota A; Mracec M; Gruia A; Rad-Curpăn R; Ostopovici-Halip L; Mracec M
    Eur J Med Chem; 2011 Mar; 46(3):877-84. PubMed ID: 21277656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of CoMFA and CoMSIA models of cytotoxicity data of anti-HIV-1-phenylamino-1H-imidazole derivatives.
    Basu A; Jasu K; Jayaprakash V; Mishra N; Ojha P; Bhattacharya S
    Eur J Med Chem; 2009 Jun; 44(6):2400-7. PubMed ID: 19000644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CP-MLR/PLS directed QSAR study on the glutaminyl cyclase inhibitory activity of imidazoles: rationales to advance the understanding of activity profile.
    Kumar V; Gupta MK; Singh G; Prabhakar YS
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):515-22. PubMed ID: 22304474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring selectivity requirements for peripheral versus central benzodiazepine receptor binding affinity: QSAR modeling of 2-phenylimidazo[1,2-a]pyridine acetamides using topological and physicochemical descriptors.
    Dalai MK; Leonard JT; Roy K
    Indian J Biochem Biophys; 2006 Apr; 43(2):105-18. PubMed ID: 16955759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.